OTCM
SCOLF
Market cap156mUSD
, Last price
USD
Name
Seed Co Ltd
Chart & performance
P/E
—
P/S
—
EPS
37.50
Div yield, %
—
Shrs. gr., 5y
3.87%
Rev. gr., 5y
3.47%
Revenues
33.94b
+2.14%
Net income
1.14b
+3.89%
CFO
2.69b
-9.66%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
SEED Co.,Ltd. is an international manufacturer and supplier specializing in a broad spectrum of ophthalmic products. The company's extensive range includes various contact lenses, lens care solutions, fashionable spectacle frames, and other vision enhancement items, serving customers in Japan and across global markets. Their diverse contact lens collection features numerous daily disposable options, such as the SEED 1dayPure moisture, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV. They also offer specialized daily lenses, including multistage and astigmatism-correcting versions like the SEED 1dayPure moisture for astigmatism. Furthermore, SEED provides two-week disposable lenses through its SEED 2weekPure moisture series, which encompasses standard, multistage bifocal, and astigmatism-specific variants. Monthly replacement lenses, such as SEED MonthlyFine UV and monthly color lens UV, are also part of their portfolio, alongside advanced rigid gas permeable and medical contact lenses. In addition to vision correction products, SEED Co.,Ltd. designs and sells eyewear frames under well-known brands like Vivid Moon, ViVi fleurs, and Plusmix. The company also develops pharmaceutical products, including Adeno Test AD for the detection of adenovirus antigens, and other solutions aimed at improving visual health. Established in 1957, SEED Co.,Ltd. is based in Tokyo, Japan.
Key people
Takayasu Arai
Managing Executive Officer, Chief Director of Business Strategy, Director · since 2013
Kazuhiro Katayama
Managing Executive Officer, Chief Director of Administration, Director · since 2016
Takao Sato
Managing Executive Officer, Chief Director of Research & Development · since 2018
Tetsuya Sugiyama
Managing Executive Officer, Deputy Chief Director of Administration, Director of Accounting · since 2018
Tamotsu Hitomi
Executive Officer, Chief Director of Quality Assurance, Director of Quality Management · since 2015
Jun Igarashi
Executive Officer, Director of Audit Office · since 2017
Roji Kimura
Executive Officer, Director of Business Planning, Director of President's Office in Business Planning Unit · since 2018
Yuichiro Nojima
Executive Officer, Chief Director of Overseas Business, Director of Overseas Business · since 2015
Takanori Yasuda
Executive Officer, Director in charge of Main Sales Unit
Managing Executive Officer, Chief Director of Production Technology, Director · since 2018
Hitoshi Hosokawa
Managing Executive Officer, Chief Director of Sales, Director · since 2016
Kiyoshi Kamada
Managing Executive Officer, Chief Director of Administration, Director · since 2013
Masahiro Urakabe
President, Representative Director · since 2013
Keiji Yajima
Director · since 2018
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||